Cargando…

Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis

OBJECTIVE: To study whether the circadian variation of plasminogen-activator-inhibitor-1 (PAI-1) levels, with high morning levels, is associated with poor outcome of children with meningococcal sepsis presenting in the morning hours. DESIGN: Retrospective analysis of prospectively collected clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boeddha, Navin P., Driessen, Gertjan J., Cnossen, Marjon H., Hazelzet, Jan A., Emonts, Marieke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125643/ https://www.ncbi.nlm.nih.gov/pubmed/27893784 http://dx.doi.org/10.1371/journal.pone.0167004

Ejemplares similares

Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis
por: de Haan, Noortje, et al.
Publicado: (2018)

Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis
por: Hartman, Stan J. F., et al.
Publicado: (2019)

Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study
por: Hagedoorn, Nienke N., et al.
Publicado: (2022)

Translating Sepsis-3 Criteria in Children: Prognostic Accuracy of Age-Adjusted Quick SOFA Score in Children Visiting the Emergency Department With Suspected Bacterial Infection
por: van Nassau, Sietske C., et al.
Publicado: (2018)

Increased CD4(+) T Cell Co-Inhibitory Immune Receptor CEACAM1 in Neonatal Sepsis and Soluble-CEACAM1 in Meningococcal Sepsis: A Role in Sepsis-Associated Immune Suppression?
por: van der Flier, Michiel, et al.
Publicado: (2013)

Group A streptococcal disease in paediatric inpatients: a European perspective
por: Boeddha, Navin P., et al.
Publicado: (2022)

Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study
por: Verhoeven, Jennifer J, et al.
Publicado: (2011)

CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity
por: Vermont, Clementien L, et al.
Publicado: (2006)

A new scoring system derived from base excess and platelet count at presentation predicts mortality in paediatric meningococcal sepsis
por: Couto-Alves, Alexessander, et al.
Publicado: (2013)

One single dose of etomidate negatively influences adrenocortical performance for at least 24 h in children with meningococcal sepsis
por: den Brinker, Marieke, et al.
Publicado: (2007)

Improved survival of children with sepsis and purpura: effects of age, gender, and era
por: Maat, Martine, et al.
Publicado: (2007)

Detectable A Disintegrin and Metalloproteinase With Thrombospondin Motifs-1 in Serum Is Associated With Adverse Outcome in Pediatric Sepsis
por: Boeddha, Navin P., et al.
Publicado: (2021)

Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS)
por: Boeddha, Navin P., et al.
Publicado: (2018)

Outcome research in meningococcal septic shock
por: Buysse, Corinne, et al.
Publicado: (2008)

Bench-to-bedside review: Genetic influences on meningococcal disease
por: Vermont, Clementien L, et al.
Publicado: (2002)

Validation of an adapted Pediatric Sepsis Score in children admitted to PICU with invasive infection and sepsis: a retrospective analysis of a Dutch national cohort
por: Boeddha, Navin P., et al.
Publicado: (2022)

Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations
por: Kumar, Vikrant, et al.
Publicado: (2022)

Identification of regulatory variants associated with genetic susceptibility to meningococcal disease
por: Borghini, Lisa, et al.
Publicado: (2019)

Thrombomodulin, Plasminogen Activator Inhibitor-1 and Protein C Levels, and Organ Dysfunction in Sepsis
por: Katayama, Shinshu, et al.
Publicado: (2019)

Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis
por: Iba, Toshiaki, et al.
Publicado: (2017)

Does Dexamethasone Helps in Meningococcal Sepsis?
por: Tolaj, Ilir, et al.
Publicado: (2017)

Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes
por: Yu, Yongzhuo, et al.
Publicado: (2023)

Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
por: Koyama, Kansuke, et al.
Publicado: (2017)

Imaging of Disease Dynamics during Meningococcal Sepsis
por: Sjölinder, Hong, et al.
Publicado: (2007)

Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis
por: Hoshino, Kota, et al.
Publicado: (2017)

Validating plasminogen activator inhibitor‐1 as a poor prognostic factor in sepsis
por: Hoshino, Kota, et al.
Publicado: (2020)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

A novel explanation for profound shock in meningococcal sepsis
por: Holland, PC, et al.
Publicado: (1999)

An Unexpected Fever Post Serogroup B Meningococcal Sepsis
por: Donà, Daniele, et al.
Publicado: (2016)

Effect of Hemoadsorption for Cytokine Removal in Pneumococcal and Meningococcal Sepsis
por: Leonardis, Francesca, et al.
Publicado: (2018)

Plasminogen System in the Pathophysiology of Sepsis: Upcoming Biomarkers
por: Napolitano, Filomena, et al.
Publicado: (2023)

Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis
por: Staels, F., et al.
Publicado: (2022)

Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis
por: van den Akker, Erica L. T., et al.
Publicado: (2009)

Sepsis
por: Wynn, James L., et al.
Publicado: (2014)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

The Role of Plasminogen Activator Inhibitor 1 in Predicting Sepsis-Associated Liver Dysfunction: An Observational Study
por: Woźnica-Niesobska, Ewa, et al.
Publicado: (2023)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
por: Jasmiad, Nurbadriah binti, et al.
Publicado: (2022)

Improving access to healthcare for paediatric sickle cell disease patients: a qualitative study on healthcare professionals’ views
por: Houwing, Maite E., et al.
Publicado: (2021)

The GH/IGF-I axis in children with a meningococcal septic shock: striking differences between survivors and non-survivors
por: de Groof, F, et al.
Publicado: (2000)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_q0ioles7lufs9rkborhqboe8eq